DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)
13.42
-0.38 (-2.75%)
Sep 6, 2024, 3:00 PM CST
DaShenLin Pharmaceutical Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 5,047 | 4,416 | 4,493 | 2,792 | 3,750 | 1,716 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 903.8 | Upgrade
|
Trading Asset Securities | 16.85 | 41.99 | 91.99 | 109.37 | 689.98 | - | Upgrade
|
Cash & Short-Term Investments | 5,064 | 4,458 | 4,585 | 2,902 | 4,440 | 2,620 | Upgrade
|
Cash Growth | 50.99% | -2.76% | 58.01% | -34.65% | 69.49% | 97.13% | Upgrade
|
Accounts Receivable | 1,224 | 1,234 | 1,022 | 743.82 | 432.32 | 355.69 | Upgrade
|
Other Receivables | 464 | 436.53 | 368.24 | 308.18 | 226.97 | 219.82 | Upgrade
|
Receivables | 1,688 | 1,671 | 1,390 | 1,052 | 659.29 | 575.52 | Upgrade
|
Inventory | 4,285 | 4,181 | 3,872 | 3,630 | 2,683 | 2,055 | Upgrade
|
Prepaid Expenses | 3.94 | 11.97 | 39.03 | 43.79 | - | 111.66 | Upgrade
|
Other Current Assets | 442.37 | 476.21 | 783.06 | 240.19 | 515.14 | 105.91 | Upgrade
|
Total Current Assets | 11,483 | 10,798 | 10,670 | 7,868 | 8,297 | 5,468 | Upgrade
|
Property, Plant & Equipment | 7,423 | 7,301 | 6,095 | 5,654 | 1,287 | 1,119 | Upgrade
|
Long-Term Investments | 155.59 | 155.59 | 132.16 | 150.17 | 150.3 | 116.95 | Upgrade
|
Goodwill | 3,481 | 3,024 | 2,364 | 2,060 | 1,334 | 983.73 | Upgrade
|
Other Intangible Assets | 1,943 | 1,859 | 637.19 | 618.8 | 489.98 | 351.93 | Upgrade
|
Long-Term Deferred Tax Assets | 213.59 | 214.48 | 186.31 | 157.57 | 41.53 | 38.38 | Upgrade
|
Long-Term Deferred Charges | 722.31 | 670.03 | 663.03 | 669.76 | 571.86 | 491.73 | Upgrade
|
Other Long-Term Assets | 66.79 | 101.12 | 94.19 | 157.99 | 160.02 | 102.04 | Upgrade
|
Total Assets | 25,489 | 24,123 | 20,841 | 17,336 | 12,332 | 8,672 | Upgrade
|
Accounts Payable | 7,796 | 6,871 | 6,127 | 4,738 | 4,215 | 3,200 | Upgrade
|
Accrued Expenses | 507.75 | 757.54 | 809.87 | 488.83 | 449.34 | 342.73 | Upgrade
|
Short-Term Debt | 1,164 | 744.89 | 697.31 | 165.44 | 190.86 | 63.47 | Upgrade
|
Current Portion of Long-Term Debt | 33.87 | 14.84 | 7.64 | - | 1.04 | 5.37 | Upgrade
|
Current Portion of Leases | 1,177 | 1,041 | 974.67 | 905.59 | - | - | Upgrade
|
Current Income Taxes Payable | 102.11 | 176.21 | 138.41 | 98.67 | 135.51 | 68.81 | Upgrade
|
Current Unearned Revenue | 368.14 | 362.4 | 435.73 | 164.11 | 68.11 | 44.91 | Upgrade
|
Other Current Liabilities | 1,147 | 1,486 | 516.59 | 615.14 | 408.79 | 277.94 | Upgrade
|
Total Current Liabilities | 12,296 | 11,454 | 9,708 | 7,176 | 5,468 | 4,003 | Upgrade
|
Long-Term Debt | 1,799 | 1,638 | 1,461 | 1,252 | 1,207 | 260.45 | Upgrade
|
Long-Term Leases | 2,996 | 3,070 | 2,790 | 2,952 | - | - | Upgrade
|
Long-Term Unearned Revenue | 17.81 | 19.3 | 17.64 | 20.12 | 83.27 | 76.94 | Upgrade
|
Other Long-Term Liabilities | 7.66 | 9.67 | 0.33 | - | - | - | Upgrade
|
Total Liabilities | 17,116 | 16,190 | 13,977 | 11,400 | 6,759 | 4,340 | Upgrade
|
Common Stock | 1,139 | 1,139 | 949.12 | 790.93 | 658.62 | 539.54 | Upgrade
|
Additional Paid-In Capital | 1,346 | 1,355 | 1,537 | 1,643 | 1,762 | 1,515 | Upgrade
|
Retained Earnings | 4,475 | 4,170 | 3,573 | 2,933 | 2,874 | 2,140 | Upgrade
|
Treasury Stock | -41.17 | -29.72 | -36.68 | -77.59 | -99.41 | - | Upgrade
|
Comprensive Income & Other | 189.92 | 189.94 | 189.94 | 189.96 | 189.97 | 45.71 | Upgrade
|
Total Common Equity | 7,109 | 6,824 | 6,212 | 5,479 | 5,385 | 4,240 | Upgrade
|
Minority Interest | 1,264 | 1,109 | 652.27 | 457.3 | 188.09 | 91.8 | Upgrade
|
Shareholders' Equity | 8,372 | 7,933 | 6,864 | 5,936 | 5,573 | 4,332 | Upgrade
|
Total Liabilities & Equity | 25,489 | 24,123 | 20,841 | 17,336 | 12,332 | 8,672 | Upgrade
|
Total Debt | 7,169 | 6,508 | 5,931 | 5,275 | 1,399 | 329.29 | Upgrade
|
Net Cash (Debt) | -2,106 | -2,050 | -1,346 | -2,373 | 3,041 | 2,291 | Upgrade
|
Net Cash Growth | - | - | - | - | 32.77% | 134.65% | Upgrade
|
Net Cash Per Share | -1.86 | -1.81 | -1.18 | -2.10 | 2.68 | 2.08 | Upgrade
|
Filing Date Shares Outstanding | 1,139 | 1,139 | 1,139 | 1,139 | 1,138 | 1,119 | Upgrade
|
Total Common Shares Outstanding | 1,139 | 1,139 | 1,139 | 1,139 | 1,138 | 1,119 | Upgrade
|
Working Capital | -813.55 | -655.27 | 962.03 | 692.26 | 2,829 | 1,465 | Upgrade
|
Book Value Per Share | 6.24 | 5.99 | 5.45 | 4.81 | 4.73 | 3.79 | Upgrade
|
Tangible Book Value | 1,684 | 1,941 | 3,211 | 2,800 | 3,561 | 2,904 | Upgrade
|
Tangible Book Value Per Share | 1.48 | 1.70 | 2.82 | 2.46 | 3.13 | 2.60 | Upgrade
|
Buildings | 2,206 | 2,016 | 1,076 | 800.43 | 775.04 | 625.88 | Upgrade
|
Machinery | 1,525 | 1,460 | 1,257 | 1,119 | 938.4 | 758.63 | Upgrade
|
Construction In Progress | 757.53 | 874.53 | 1,049 | 765.67 | 170.91 | 181.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.